Coherus BioSciences to Present at Upcoming Investor Conferences in May

REDWOOD CITY, Calif., May 04, 2023 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus“, Nasdaq: CHRS) today announced that senior management will participate in the following investor conferences:

  • Bank of America Merrill Lynch Global Healthcare 2023 Conference in Las Vegas on Thursday, May 11, 2023; fireside chat at 10:15 a.m. PDT
  • UBS Global Healthcare Conference at UBS NY headquarters on Tuesday, May 23, 2023 for 1x1 meetings only between 8:00 a.m. and 5:00 p.m. EDT

An audio webcast of the fireside chat presentation will be available on the investors’ page of the Coherus website at http://investors.coherus.com. Please access the website prior to the start of the presentation to ensure a timely connection to the webcast. The webcast will be archived on the Coherus website for 30 days.

Coherus Contact Information:
Marek Ciszewski, SVP Investor Relations
IR@coherus.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  229.59
+3.31 (1.46%)
AAPL  278.62
+2.70 (0.98%)
AMD  199.07
-15.98 (-7.43%)
BAC  52.70
+0.77 (1.49%)
GOOG  321.76
+3.29 (1.03%)
META  630.12
+17.07 (2.78%)
MSFT  475.96
+1.96 (0.41%)
NVDA  175.44
-7.11 (-3.89%)
ORCL  196.34
-3.94 (-1.97%)
TSLA  418.34
+0.56 (0.13%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.